(WBA) Walgreens Boots Alliance - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9314271084

WBA: Pharmacy, Health, Beauty, Personal Care, Retail

Walgreens Boots Alliance Inc (NASDAQ:WBA) is a leading healthcare, pharmacy, and retail company with operations in the United States, Germany, the United Kingdom, and other international markets. Established in 1909 and headquartered in Deerfield, Illinois, the company is structured into three key segments: U.S. Retail Pharmacy, International, and U.S. Healthcare.

The U.S. Retail Pharmacy segment manages a network of retail drugstores, offering a range of services including health and wellness, specialty pharmacy, and home delivery. This segment also provides an assortment of beauty, personal care, and general merchandise products.

Internationally, the company operates under well-known brands such as Boots in the UK, Ireland, Thailand, and Chile, where it is recognized for its pharmacy-led health and beauty retail services. Additionally, it operates under the Benavides brand in Mexico and the Ahumada brand in Chile, offering prescription drugs and consumer products.

The U.S. Healthcare segment focuses on value-based care through VillageMD, which provides primary, specialty, and urgent care services. It also includes Shields, a specialty pharmacy integrator, and CareCentrix, a leader in post-acute and home care management.

Based on technical and fundamental analysis, the 3-month forecast for WBA indicates potential short-term gains due to bullish SMA crossover signals, with price expected to fluctuate between $10.80 and $11.40. However, long-term trends suggest caution due to the stock price hovering below the SMA200 level. The low ATR of 0.17 signals minimal volatility, while the forward P/E of 7.00 and P/S of 0.06 suggest undervaluation. Despite this, the negative RoE of -81.28 may pose challenges.

Additional Sources for WBA Stock

WBA Stock Overview

Market Cap in USD 9,486m
Sector Healthcare
Industry Pharmaceutical Retailers
GiC Sub-Industry Drug Retail
IPO / Inception 1985-07-01

WBA Stock Ratings

Growth Rating -67.8
Fundamental -28.3
Dividend Rating 33.4
Rel. Strength -29.4
Analysts 3.14/5
Fair Price Momentum 9.51 USD
Fair Price DCF 14.17 USD

WBA Dividends

Dividend Yield 12m 6.95%
Yield on Cost 5y 2.35%
Annual Growth 5y -11.60%
Payout Consistency 96.5%

WBA Growth Ratios

Growth Correlation 3m 21.3%
Growth Correlation 12m -13%
Growth Correlation 5y -80.3%
CAGR 5y -19.13%
CAGR/Max DD 5y -0.23
Sharpe Ratio 12m -1.15
Alpha -37.23
Beta 0.203
Volatility 31.15%
Current Volume 10205k
Average Volume 20d 7954.5k
What is the price of WBA stocks?
As of May 09, 2025, the stock is trading at USD 11.05 with a total of 10,205,019 shares traded.
Over the past week, the price has changed by +0.73%, over one month by +3.17%, over three months by +9.19% and over the past year by -31.87%.
Is Walgreens Boots Alliance a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Walgreens Boots Alliance (NASDAQ:WBA) is currently (May 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -28.26 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WBA as of May 2025 is 9.51. This means that WBA is currently overvalued and has a potential downside of -13.94%.
Is WBA a buy, sell or hold?
Walgreens Boots Alliance has received a consensus analysts rating of 3.14. Therefor, it is recommend to hold WBA.
  • Strong Buy: 2
  • Buy: 0
  • Hold: 11
  • Sell: 0
  • Strong Sell: 1
What are the forecast for WBA stock price target?
According to ValueRays Forecast Model, WBA Walgreens Boots Alliance will be worth about 10.3 in May 2026. The stock is currently trading at 11.05. This means that the stock has a potential downside of -7.06%.
Issuer Forecast Upside
Wallstreet Target Price 12.3 11.2%
Analysts Target Price 12.3 11.2%
ValueRay Target Price 10.3 -7.1%